Nabi (NABI) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech
Nabi (NABI)

An SI Board Since January 1997

Posts	SubjectMarks	Bans	Symbol
354	22	0	NABI

Emcee: The BayWatcher	Type: Unmoderated

Introduction Market Data Compact

Now that biotechs are starting to get hot again,

we're all going to start hearing about NABI. NABI

is a top-tier biotech and is the 4th or 5th largest

biotech company in the U.S. It is also making a

profit. NABI trades at a huge discount compared to

its peers. With a drug pipeline that is very

strong, NABI is set to file for FDA approval for

their HBIG product by March 1997 and has other very

promising products in Phase II and Phase III

trials. In addition to the drug pipeline, NABI's

blood plasma business is booming; the CEO said in a

biotech conference call yesterday that its 1997

supply of blood plasma is "totally committed" and

that they are working on increasing their supply to

meet 1998 demand. All this bodes well for NABI and

its shareholders who may see the stock double in

1997. Please ad your comments and views on this

great company.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
354	I guess that's why they don't want the FDA to regulate tobacco. :)	kenhott	-	5/12/2006
353	<i>The most common side effects of Chantix seen in clinical trials were na	Hawkmoon	-	5/11/2006
352	PFE's smoke cessation drug approved: Message 22439245 From WSJ.. The agen	kenhott	-	5/11/2006
351	Thanks for the nudge. Can't seem to get it to run at the moment, but will k	keokalani'nui	-	3/23/2006
350	The replay CC is up: phx.corporate-ir.net If you haven't listen, you shoul	kenhott	-	3/23/2006
349	I could see why StaphVAX and Altastaph should not work. But I was not sold that	kenhott	-	3/22/2006
348	You should be holding 100% for now. Upgrades coming. Partnership negotiations.	keokalani'nui	-	3/22/2006
347	I 2x my holdings this morning. Have to still figure out what to trade, hold, se	kenhott	-	3/22/2006
346	I'm in for some. $5.44.	keokalani'nui	-	3/22/2006
345	Glad you had bought.	kenhott	-	3/22/2006
344	what interesting news.... sold the last of my holding a few weeks ago. glad the	Extra Pale	-	3/21/2006
343	Little more details from PR: The quality or functional characteristics of the a	kenhott	-	3/21/2006
342	Extra Pale, still out there? UPDATE 1-Nabi says to resume developing staph vacc	kenhott	-	3/21/2006
341	<i>Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for NicVA	Hawkmoon	-	3/9/2006
340	NABI, Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for NicVAX(	manny t	-	3/9/2006
339	I picked up a position in NABI this morning. I think that the stock has formed	Hawkmoon	-	2/2/2006
338	Big announcement on Foxnews today about a Nicotine Vaccine. foxnews.com This c	R.D. Ryan	-	12/1/2005
337	bank america analyst reduced price target from $18 to $5 (excludes $1net cash &a	Extra Pale	-	11/1/2005
336	<b>But Tuesday's announcement said that in a trial of more than 3,600	blind-geezer	-	11/1/2005
335	am hoping Rick Harmon or one of the other SI scientists will comment on trial fa	Extra Pale	-	11/1/2005
334	totally failure at phase 3, not even slightly better than a placebo, WTF is that	blind-geezer	-	11/1/2005
333	my sincere regrets for your loss. have had several biotech disasters in my portf	Extra Pale	-	11/1/2005
332	I think I am totally ruined ...	blind-geezer	-	11/1/2005
331	Nabi cc, limited notes: - titer rates of antibodies higher in confirmatory than	Extra Pale	-	11/1/2005
330	I too took a bite at 4.03/share. They appear to have $3 in cash, I think it is	R. E. Simpson	-	11/1/2005

Go to reply# or date (mm/dd/yy):